HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew Krivoshik Selected Research

ASP9853

3/2016ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew Krivoshik Research Topics

Disease

9Prostatic Neoplasms (Prostate Cancer)
11/2019 - 01/2016
7Neoplasms (Cancer)
11/2019 - 08/2006
3Disease Progression
01/2018 - 12/2017
2Seizures (Absence Seizure)
01/2018 - 12/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2017 - 03/2011
2Lung Neoplasms (Lung Cancer)
12/2017 - 03/2016
2Diarrhea
10/2013 - 03/2011
2Fatigue
03/2011 - 02/2008
2Neuroblastoma
09/2010 - 01/2010
1Neoplasm Metastasis (Metastasis)
06/2018
1Pathologic Complete Response
05/2017
1Residual Neoplasm
05/2017
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2016
1Colorectal Neoplasms (Colorectal Cancer)
10/2016
1Neutropenia
03/2016
1Hypertension (High Blood Pressure)
10/2013
1Dysphonia (Spastic Dysphonia)
10/2013
1Renal Cell Carcinoma (Grawitz Tumor)
10/2013
1Anemia
03/2011
1Nausea
03/2011
1Constipation
03/2011

Drug/Important Bio-Agent (IBA)

8enzalutamideIBA
11/2019 - 01/2016
6ABT751IBA
07/2013 - 08/2006
4Prostate-Specific Antigen (Semenogelase)IBA
11/2019 - 12/2017
4Androgen Receptors (Androgen Receptor)IBA
01/2018 - 01/2016
2AndrogensIBA
06/2018 - 05/2017
2Tyrosine Kinase InhibitorsIBA
12/2017 - 10/2013
2tivozanibIBA
10/2016 - 10/2013
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2016 - 10/2013
2Tubulin ModulatorsIBA
02/2008 - 08/2006
1Hormones (Hormone)IBA
01/2018
1Testosterone (Sustanon)FDA Link
01/2018
1ErbB Receptors (EGF Receptor)IBA
12/2017
1Cell-Free Nucleic AcidsIBA
12/2017
1naquotinibIBA
12/2017
1Dutasteride (Avodart)FDA Link
05/2017
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2017
1Leuprolide (Lupron)FDA LinkGeneric
05/2017
1Bevacizumab (Avastin)FDA Link
10/2016
1Antineoplastic Agents (Antineoplastics)IBA
10/2016
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2016
1Docetaxel (Taxotere)FDA Link
03/2016
1ASP9853IBA
03/2016
1taxaneIBA
03/2016
1bicalutamide (Casodex)FDA LinkGeneric
01/2016
1Sorafenib (BAY 43-9006)FDA Link
10/2013
1Pemetrexed (MTA)FDA Link
03/2011
1TubulinIBA
01/2010

Therapy/Procedure

7Castration
11/2019 - 01/2016
5Therapeutics
11/2019 - 10/2013
4Drug Therapy (Chemotherapy)
11/2019 - 01/2016
1Duration of Therapy
01/2018
1Neoadjuvant Therapy
05/2017
1Prostatectomy (Retropubic Prostatectomy)
05/2017